Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1133020 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL12980679 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL17336921 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL117759 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL1863853 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL23365822 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL17627766 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL117760 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL20912969 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA | |
| SCHEMBL1863854 | 1.00 | MAPT (0.58) | MAPTMAPK1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9408407-B2 | Compounds, compositions, and methods for reducing or eliminating bitter taste | CHROMOCELL CORPORATION (US) | 2016-08-09 | — | — | US | disclosed |
| US-20150237900-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | CHROMOCELL CORP (US) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150237900-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | TAS2R5, TAS2R20, TAS2R10 | MAPT 4340/4885MAPK1 3212/4885KMT2A 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.